Written Informed Consent Act

HR 4837, the Written Informed Consent Act, requires the Veterans Health Administration (VHA) to update its existing directive on informed consent to include additional medication classes. Specifically, it mandates that written informed consent must be obtained before prescribing antipsychotics, stimulants, antidepressants, anti-anxiety medications (anxiolytics), and narcotics (opioids) to veterans. This expansion directly affects veterans receiving these medications through the VA system, ensuring they are informed about specific treatment risks and alternatives. The key mechanism is amending VHA Directive 1005 to broaden its application beyond long-term opioid therapy to cover the newly listed medication types.